Bullish
Citizens initiates Biomea Fusion stock coverage citing diabetes treatment potential
Citizens initiated coverage on Biomea Fusion Inc. (NASDAQ:BMEA) with a Market Outperform rating and a $9.00 price target, highlighting the company's s...